Basel/Berlin 20 June 2018: The Straumann Group and botiss biomaterials are pleased to announce the opening of the 2018 Young Pro Award in Regenerative Dentistry. Currently in its third cycle, the Award aims to promote and encourage the development of young dental professionals in the field of regenerative dentistry and dental biomaterials research.
Dental professionals, students and researchers under the age of 35 are invited to compete for the prize by submitting original work that contributes to the advancement of treatment/care in regenerative dentistry or to research in the field. Dissertations, projects or practical work-experience may form the basis of the submission. The entries will be adjudicated by a distinguished panel of experts in the field.
The 2018 award will be presented at the botiss bone&tissue days World Congress on 9–10 November in Berlin. The winner will receive a cash prize of 10 000 euros and – together with the two runners-up – will be offered a free trip to the Congress. The winning submission will be published in STARGET DIGITAL.
Complete details and the application process can be found at
2015: Andreas Pabst, DMD, was a resident in Oral- and Maxillofacial surgery at the Federal Armed Forces hospital in Koblenz, Germany, and a researcher at the University Medical Center Mainz. His winning entry was entitled: ‘In-vitro and in-vivo characterization of biocompatibility and biomechanical properties of a new acellular collagen matrix (mucoderm®)’.
2016: Vítor Sapata, MSc., was a practitioner from Maringá, Brazil and Research Scholar at the University of Zurich Clinic for Fixed and Removable Prosthodontics and Dental Material Science. The subject of his work was localized bone regeneration around dental implants using biological mediators.
Based in Berlin, botiss biomaterials is a leading international supplier of oral tissue regeneration products. Its full range of clinically-proven, high quality solutions includes membranes for guided tissue and bone regeneration, a full range of bovine, allogenic and synthetic bone-graft materials, as well as soft-tissue-graft products. botiss is a fast-growing entrepreneurial company, whose products are used in leading clinics across Europe and are backed by many years of clinical experience. The company prides itself in innovations, such as its maxgraft® bonering for simultaneous implant placement and bone augmentation, as well as its maxgraft® bonebuilder, a CADCAM bone block customized for individual patients. The company has a promising innovation pipeline, which should further differentiate it as a leader in regenerative dentistry. botiss is privately owned and was founded in 2008 by Managing Partners Oliver Bielenstein and Dr. Dražen Tadić.
About the Straumann Group
With botiss and its other partners, the Straumann Group offers an unparalleled range of regenerative solutions to support implant and periodontal procedures. The great advantage for customers is that they can obtain total solutions conveniently from a single provider together with service and support.
The Straumann Group (SIX: STMN) is a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence. It unites global and international brands that stand for excellence, innovation and quality in replacement, corrective and digital dentistry, including Straumann, Neodent, Medentika, ClearCorrect, Dental Wings, and other fully/partly owned companies and partners. In collaboration with leading clinics, institutes and universities, the Group researches, develops, manufactures and supplies dental implants, instruments, CADCAM prosthetics, digital and orthodontic solutions, as well as biomaterials for applications in replacement, restorative, esthetic and preventative dentistry.
Headquartered in Basel, Switzerland, the Group currently employs approx. 5000 people worldwide and its products, solutions and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.